(PAGP) Plains GP Holdings - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US72651A1088
Stock: Crude Oil, Natural Gas, Liquids, Storage, Transportation
Total Rating 40
Risk 50
Buy Signal 0.53
| Risk 5d forecast | |
|---|---|
| Volatility | 24.4% |
| Relative Tail Risk | 2.09% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.83 |
| Alpha | 8.72 |
| Character TTM | |
|---|---|
| Beta | 0.539 |
| Beta Downside | 0.608 |
| Drawdowns 3y | |
|---|---|
| Max DD | 21.02% |
| CAGR/Max DD | 1.62 |
EPS (Earnings per Share)
Revenue
Description: PAGP Plains GP Holdings March 05, 2026
Plains GP Holdings, L.P. (PAGP) is an owner and operator of midstream energy infrastructure in the United States and Canada. Midstream companies primarily focus on the transportation and storage of oil and gas products.
The company operates in two segments: Crude Oil and Natural Gas Liquids (NGLs). Its activities include gathering, transporting (via pipelines, trucks, barges, and railcars), terminalling, and storing crude oil. NGL fractionation is a key process in separating NGLs into their individual components.
PAGP also engages in natural gas processing, NGL fractionation, storage, transportation, and terminalling. PAA GP Holdings LLC serves as the general partner. Further research on ValueRay can provide more in-depth analysis of PAGPs financial performance and operational metrics.
Headlines to watch out for
- Crude oil transportation volumes impact revenue
- NGL processing and fractionation margins affect profitability
- Regulatory changes for pipeline operations create risk
- Global energy demand influences commodity prices
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income: 259.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 0.80 > 1.0 |
| NWC/Revenue: -0.44% < 20% (prev 0.32%; Δ -0.76% < -1%) |
| CFO/TA 0.09 > 3% & CFO 2.93b > Net Income 259.0m |
| Net Debt (9.52b) to EBITDA (2.87b): 3.32 < 3 |
| Current Ratio: 0.96 > 1.5 & < 3 |
| Outstanding Shares: last quarter (198.0m) vs 12m ago 12.50% < -2% |
| Gross Margin: 6.82% > 18% (prev 0.29%; Δ 653.2% > 0.5%) |
| Asset Turnover: 154.9% > 50% (prev 187.9%; Δ -32.95% > 0%) |
| Interest Coverage Ratio: 4.17 > 6 (EBITDA TTM 2.87b / Interest Expense TTM 466.0m) |
Altman Z''
| A: -0.01 (Total Current Assets 4.70b - Total Current Liabilities 4.90b) / Total Assets 31.28b |
| B: error (Retained Earnings missing) |
| C: 0.07 (EBIT TTM 1.94b / Avg Total Assets 28.92b) |
| D: 0.08 (Book Value of Equity 1.34b / Total Liabilities 17.06b) |
Beneish M
| DSRI: none (Receivables none/3.90b, Revenue 44.80b/49.90b) |
| GMI: 4.22 (GM 6.82% / 28.81%) |
| AQI: 1.41 (AQ_t 0.30 / AQ_t-1 0.22) |
| SGI: 0.90 (Revenue 44.80b / 49.90b) |
| TATA: -0.09 (NI 259.0m - CFO 2.93b) / TA 31.28b) |
| Beneish M-Score: cannot calculate (missing components) |
What is the price of PAGP shares?
As of March 12, 2026, the stock is trading at USD 23.42 with a total of 1,542,404 shares traded.
Over the past week, the price has changed by -0.13%, over one month by +10.58%, over three months by +27.50% and over the past year by +23.10%.
Over the past week, the price has changed by -0.13%, over one month by +10.58%, over three months by +27.50% and over the past year by +23.10%.
Is PAGP a buy, sell or hold?
Plains GP Holdings has received a consensus analysts rating of 3.77.
Therefor, it is recommend to hold PAGP.
- StrongBuy: 6
- Buy: 0
- Hold: 5
- Sell: 2
- StrongSell: 0
What are the forecasts/targets for the PAGP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 21.4 | -8.7% |
| Analysts Target Price | 21.4 | -8.7% |
PAGP Fundamental Data Overview March 12, 2026
P/E Trailing = 21.1607
P/E Forward = 15.1745
P/S = 0.1248
P/B = 0.4719
P/EG = 0.6972
Revenue TTM = 44.80b USD
EBIT TTM = 1.94b USD
EBITDA TTM = 2.87b USD
Long Term Debt = 8.44b USD (from longTermDebt, two quarters ago)
Short Term Debt = 202.0m USD (from shortTermDebt, last quarter)
Debt = 9.52b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.52b USD (from netDebt column, last quarter)
Enterprise Value = 10.31b USD (5.52b + Debt 9.52b - CCE 4.73b)
Interest Coverage Ratio = 4.17 (Ebit TTM 1.94b / Interest Expense TTM 466.0m)
EV/FCF = 4.26x (Enterprise Value 10.31b / FCF TTM 2.42b)
FCF Yield = 23.47% (FCF TTM 2.42b / Enterprise Value 10.31b)
FCF Margin = 5.40% (FCF TTM 2.42b / Revenue TTM 44.80b)
Net Margin = 0.58% (Net Income TTM 259.0m / Revenue TTM 44.80b)
Gross Margin = 6.82% ((Revenue TTM 44.80b - Cost of Revenue TTM 41.74b) / Revenue TTM)
Gross Margin QoQ = 6.75% (prev 6.09%)
Tobins Q-Ratio = 0.33 (Enterprise Value 10.31b / Total Assets 31.28b)
Interest Expense / Debt = 1.44% (Interest Expense 137.0m / Debt 9.52b)
Taxrate = 4.97% (16.0m / 322.0m)
NOPAT = 1.85b (EBIT 1.94b * (1 - 4.97%))
Current Ratio = 0.96 (Total Current Assets 4.70b / Total Current Liabilities 4.90b)
Debt / Equity = 7.08 (Debt 9.52b / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = 3.32 (Net Debt 9.52b / EBITDA 2.87b)
Debt / FCF = 3.93 (Net Debt 9.52b / FCF TTM 2.42b)
Total Stockholder Equity = 1.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.90% (Net Income 259.0m / Total Assets 31.28b)
RoE = 19.19% (Net Income TTM 259.0m / Total Stockholder Equity 1.35b)
RoCE = 19.86% (EBIT 1.94b / Capital Employed (Equity 1.35b + L.T.Debt 8.44b))
RoIC = 17.96% (NOPAT 1.85b / Invested Capital 10.29b)
WACC = 3.78% (E(5.52b)/V(15.04b) * Re(7.94%) + D(9.52b)/V(15.04b) * Rd(1.44%) * (1-Tc(0.05)))
Discount Rate = 7.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.64%
[DCF] Terminal Value 87.30% ; FCFF base≈2.19b ; Y1≈2.43b ; Y5≈3.15b
[DCF] Fair Price = 422.2 (EV 93.06b - Net Debt 9.52b = Equity 83.54b / Shares 197.9m; r=5.90% [WACC]; 5y FCF grow 12.47% → 2.90% )
EPS Correlation: -15.34 | EPS CAGR: -28.83% | SUE: -1.23 | # QB: 0
Revenue Correlation: -76.80 | Revenue CAGR: -6.68% | SUE: -0.11 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.32 | Chg7d=-0.225 | Chg30d=-0.225 | Revisions Net=+2 | Analysts=1
EPS current Year (2026-12-31): EPS=1.61 | Chg7d=-0.643 | Chg30d=-0.825 | Revisions Net=+1 | Growth EPS=+57.3% | Growth Revenue=+9.9%
EPS next Year (2027-12-31): EPS=2.23 | Chg7d=-0.010 | Chg30d=-0.222 | Revisions Net=+2 | Growth EPS=+38.7% | Growth Revenue=-2.1%
P/E Forward = 15.1745
P/S = 0.1248
P/B = 0.4719
P/EG = 0.6972
Revenue TTM = 44.80b USD
EBIT TTM = 1.94b USD
EBITDA TTM = 2.87b USD
Long Term Debt = 8.44b USD (from longTermDebt, two quarters ago)
Short Term Debt = 202.0m USD (from shortTermDebt, last quarter)
Debt = 9.52b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 9.52b USD (from netDebt column, last quarter)
Enterprise Value = 10.31b USD (5.52b + Debt 9.52b - CCE 4.73b)
Interest Coverage Ratio = 4.17 (Ebit TTM 1.94b / Interest Expense TTM 466.0m)
EV/FCF = 4.26x (Enterprise Value 10.31b / FCF TTM 2.42b)
FCF Yield = 23.47% (FCF TTM 2.42b / Enterprise Value 10.31b)
FCF Margin = 5.40% (FCF TTM 2.42b / Revenue TTM 44.80b)
Net Margin = 0.58% (Net Income TTM 259.0m / Revenue TTM 44.80b)
Gross Margin = 6.82% ((Revenue TTM 44.80b - Cost of Revenue TTM 41.74b) / Revenue TTM)
Gross Margin QoQ = 6.75% (prev 6.09%)
Tobins Q-Ratio = 0.33 (Enterprise Value 10.31b / Total Assets 31.28b)
Interest Expense / Debt = 1.44% (Interest Expense 137.0m / Debt 9.52b)
Taxrate = 4.97% (16.0m / 322.0m)
NOPAT = 1.85b (EBIT 1.94b * (1 - 4.97%))
Current Ratio = 0.96 (Total Current Assets 4.70b / Total Current Liabilities 4.90b)
Debt / Equity = 7.08 (Debt 9.52b / totalStockholderEquity, last quarter 1.34b)
Debt / EBITDA = 3.32 (Net Debt 9.52b / EBITDA 2.87b)
Debt / FCF = 3.93 (Net Debt 9.52b / FCF TTM 2.42b)
Total Stockholder Equity = 1.35b (last 4 quarters mean from totalStockholderEquity)
RoA = 0.90% (Net Income 259.0m / Total Assets 31.28b)
RoE = 19.19% (Net Income TTM 259.0m / Total Stockholder Equity 1.35b)
RoCE = 19.86% (EBIT 1.94b / Capital Employed (Equity 1.35b + L.T.Debt 8.44b))
RoIC = 17.96% (NOPAT 1.85b / Invested Capital 10.29b)
WACC = 3.78% (E(5.52b)/V(15.04b) * Re(7.94%) + D(9.52b)/V(15.04b) * Rd(1.44%) * (1-Tc(0.05)))
Discount Rate = 7.94% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: 33.33 | Cagr: 0.64%
[DCF] Terminal Value 87.30% ; FCFF base≈2.19b ; Y1≈2.43b ; Y5≈3.15b
[DCF] Fair Price = 422.2 (EV 93.06b - Net Debt 9.52b = Equity 83.54b / Shares 197.9m; r=5.90% [WACC]; 5y FCF grow 12.47% → 2.90% )
EPS Correlation: -15.34 | EPS CAGR: -28.83% | SUE: -1.23 | # QB: 0
Revenue Correlation: -76.80 | Revenue CAGR: -6.68% | SUE: -0.11 | # QB: 0
EPS next Quarter (2026-06-30): EPS=0.32 | Chg7d=-0.225 | Chg30d=-0.225 | Revisions Net=+2 | Analysts=1
EPS current Year (2026-12-31): EPS=1.61 | Chg7d=-0.643 | Chg30d=-0.825 | Revisions Net=+1 | Growth EPS=+57.3% | Growth Revenue=+9.9%
EPS next Year (2027-12-31): EPS=2.23 | Chg7d=-0.010 | Chg30d=-0.222 | Revisions Net=+2 | Growth EPS=+38.7% | Growth Revenue=-2.1%